<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03600129</url>
  </required_header>
  <id_info>
    <org_study_id>83/PB/2018</org_study_id>
    <nct_id>NCT03600129</nct_id>
  </id_info>
  <brief_title>Qudratus Lumborum Block for Postoperative Pain After Endoscopic Prostatectomy.</brief_title>
  <official_title>Ultrasound-guided Quadratus Lumborum Block for Postoperative Pain Control After Endoscopic Prostatectomy - Double Blinded, Placebo-controlled, Randomised Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre of Postgraduate Medical Education</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre of Postgraduate Medical Education</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic prostatectomy (LP) is characterized by substantial tissue trauma, despite its
      minimally -invasive approach. Although postoperative pain intensity is lower when compared to
      open procedures, the use of opioids is common. Retrospective review of available LP cases
      revealed that although analgesic demand varied, nearly all of our LP patients required
      opioids postoperatively. Bilateral Quadratus Lumborum Block (QLB), being one of relatively
      new features of regional anesthesia, offers good analgesia of abdominal wall, with the
      potential for control of visceral pain. This study was established to evaluate its
      effectiveness in alleviating pain after radical prostatectomy in a double - blind, placebo -
      controlled manner.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 25, 2018</start_date>
  <completion_date type="Actual">October 21, 2019</completion_date>
  <primary_completion_date type="Actual">October 21, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Double blind, placebo-controlled, randomised</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Solution used for block (local anesthetic or placebo) is known to anesthetist not involved in patient's care.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption following prostatectomy</measure>
    <time_frame>24 hours</time_frame>
    <description>Oxycodone consumption with Patient-Controlled Analgesia pump</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>24 hours</time_frame>
    <description>Pain scores assessed with Numeric Rating Scale (NRS).In this scale pain intensity is expressed using one of the numbers 0 - 10, 0 being no pain and 10 worst pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first dose of opioid</measure>
    <time_frame>24 hours</time_frame>
    <description>Time in minutes from emergence from anesthesia to the first request for opioid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioids - related complications</measure>
    <time_frame>24 hours</time_frame>
    <description>The occurence of symptoms and conditions related to the use of opioids, like nausea, ileus, itching</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>QLB with 0,375% ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>QLB with 0,9% NaCl</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Qadratus Lumborum Block</intervention_name>
    <description>Bilateral, ultrasound - guided Quadratus Lumborum Block</description>
    <arm_group_label>QLB with 0,375% ropivacaine</arm_group_label>
    <arm_group_label>QLB with 0,9% NaCl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>30 milliliters of 0.375% Ropivacaine</intervention_name>
    <description>30 milliliters of 0.375% Ropivacaine used for Quadratus Lumborum Block</description>
    <arm_group_label>QLB with 0,375% ropivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>30 milliliters of 0.9% NaCl</intervention_name>
    <description>30 milliliters of 0.9% NaCl used for Quadratus Lumborum Block</description>
    <arm_group_label>QLB with 0,9% NaCl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA status less or equal 3

          -  Scheduled for transperitoneal or extraperitoneal endoscopic prostatectomy

          -  Able to understand information provided and to sign the informed consent for
             participation in the study

        Exclusion Criteria:

          -  known allergy to local anesthetics and opioids

          -  infection in the area of block placement

          -  known chronic use of opioids, gabapentinoids and tricyclic antidepressants

          -  mental inability to understand the principles and rules of patient-controlled
             analgesia pump
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malgorzata Malec-Milewska, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Orlowski Hospital, Centre of Postgraduate Medical Education, Department of Anesthesiology and Intensive Care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care</name>
      <address>
        <city>Warsaw</city>
        <zip>01-813</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 12, 2018</study_first_submitted>
  <study_first_submitted_qc>July 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>October 21, 2019</last_update_submitted>
  <last_update_submitted_qc>October 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre of Postgraduate Medical Education</investigator_affiliation>
    <investigator_full_name>Bartosz Horosz, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>regional anesthesia</keyword>
  <keyword>quadratus lumborum block</keyword>
  <keyword>patient controlled anesthesia</keyword>
  <keyword>laparoscopic prostatectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

